Association of plasma brain natriuretic peptide levels in acute ischemic stroke subtypes and outcome.

BACKGROUND Brain natriuretic peptide (BNP) is believed to be a diagnostic marker for cardiovascular diseases, including atrial fibrillation (AF). Recent studies have incriminated BNP as a marker of cardioembolic stroke. We aimed at investigating association of plasma BNP levels in acute ischemic stroke subtypes and their outcome in Indian patients. METHODS We recruited 270 acute ischemic stroke patients within 48 hours of symptom onset and compared with 110 age- and sex-matched control subjects. This study was carried out at Yashoda Hospital, Hyderabad, India between April 2011 and March 2013. Serum BNP levels were estimated in stroke patients and control subjects. Good functional outcome at 3 months was defined as modified Rankin score (mRS) 2 or less. RESULTS Elevated BNP levels was significantly more in patients with acute ischemic stroke patients 119 (44%) compared with controls 4 (3.6%; P < .0001). Among stroke subtypes, elevated BNP levels were observed in 75% of cardioembolic strokes, 45.8% of small artery disease, 43.1% of larger artery atherosclerosis, and 34.5% of stroke of undetermined etiology. On multiple logistic regression analysis, elevated BNP levels were significantly associated with acute ischemic stroke (odds ratio [OR], 13.0; 95% confidence interval [CI], 8.1-15.4). Among stroke subtypes, significant association was seen with cardioembolic stroke (OR, 3.5; 95% CI, 2.2-7.2). Elevated BNP levels were independently associated with poor outcome (OR, 3.4; 95% CI, 1.2-13.7; P < .0001) and higher mortality (OR, 3.4; 95% CI, 1.2-13.7; P < .0001). CONCLUSIONS Elevated BNP level is an independent marker for cardioembolic stroke and poor outcome at 90 days follow-up. No significant association was seen with other stroke subtypes.

[1]  S Sasayama,et al.  Ventricular Expression of Brain Natriuretic Peptide in Hypertrophic Cardiomyopathy , 1993, Circulation.

[2]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[3]  K. Kimura,et al.  Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation A brain natriuretic peptide study , 2009, Journal of the Neurological Sciences.

[4]  H. Tomita,et al.  Elevated Plasma Brain Natriuretic Peptide Levels Independent of Heart Disease in Acute Ischemic Stroke: Correlation with Stroke Severity , 2008, Hypertension Research.

[5]  Tsutomu Takahashi,et al.  Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke , 2008, BMC neurology.

[6]  Habib-ur-Rehman,et al.  The role of leukocyte counts in patients with unstable angina pectoris or myocardial infarction; prognostic significance and correlation with plasma brain natriuretic peptide (BNP) levels. , 2011, JPMA. The Journal of the Pakistan Medical Association.

[7]  C. Molina,et al.  Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma Biomarkers , 2008, Stroke.

[8]  M. Woodward,et al.  Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease , 2005, Circulation.

[9]  Kazuto Kobayashi,et al.  Brain Natriuretic Peptide as a Predictor of Cardioembolism in Acute Ischemic Stroke Patients: Brain Natriuretic Peptide Stroke Prospective Study , 2013, European Neurology.

[10]  K. Kimura,et al.  Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation , 2011, Journal of the Neurological Sciences.

[11]  C. Passino,et al.  Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. , 2011, American journal of physiology. Heart and circulatory physiology.

[12]  A. Sarıtas,et al.  A prospective study of brain natriuretic peptide levels in three subgroups: Stroke with hypertension, stroke without hypertension, and hypertension alone , 2010, Annals of Indian Academy of Neurology.

[13]  N. Bornstein,et al.  Acute infection as a risk factor for ischemic stroke. , 1996, Stroke.

[14]  M. Woodward,et al.  Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease , 2005, Hypertension.

[15]  R. McKelvie,et al.  Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. , 2008, Clinical biochemistry.

[16]  K. Eckardt,et al.  Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. , 2008, The Biochemical journal.

[17]  Xingyong Chen,et al.  The prognostic value of combined NT-pro-BNP levels and NIHSS scores in patients with acute ischemic stroke. , 2012, Internal medicine.

[18]  R. Berger,et al.  Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: A direct comparison of N‐terminal atrial natriuretic peptide, N‐terminal brain natriuretic peptide and brain natriuretic peptide , 2005, European journal of heart failure.

[19]  S. Castro,et al.  Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA , 2007, Journal of the Neurological Sciences.

[20]  M. Emdin,et al.  The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[21]  K. Ohno,et al.  Plasma Concentrations of Brain Natriuretic Peptide in Patients with Acute Ischemic Stroke , 2005, Cerebrovascular Diseases.

[22]  J. Montaner,et al.  Blood Biomarkers in Cardioembolic Stroke , 2010, Current cardiology reviews.

[23]  K. Kimura,et al.  The combination of elevated BNP and AF as a predictor of no early recanalization after IV-t-PA in acute ischemic stroke , 2010, Journal of the Neurological Sciences.

[24]  T. Etgen,et al.  Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke Do Not Relate to Clinical Prognosis , 2005, Stroke.

[25]  Honglian Shi.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. , 2009, Current medicinal chemistry.

[26]  C. Lazzeri,et al.  [Brain natriuretic peptide]. , 1995, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

[27]  Outcome of Chlamydia pneumoniae associated acute ischemic stroke in elderly patients: A case–control study , 2012, Clinical Neurology and Neurosurgery.

[28]  K. Furie,et al.  Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke , 2012, Stroke.

[29]  G. Louridas,et al.  N-Terminal Pro-Brain Natriuretic Peptide Levels Are Elevated in Patients with Acute Ischemic Stroke , 2005, Angiology.

[30]  H. Huikuri,et al.  Natriuretic Peptides and Mortality After Stroke , 2005, Stroke.

[31]  K. Kimura,et al.  Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation , 2011, European journal of neurology.

[32]  K. Kimura,et al.  Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack , 2010, European journal of neurology.

[33]  G C Hogelin,et al.  The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. , 1985, American journal of preventive medicine.

[34]  J. Soustiel,et al.  Role of brain natriuretic peptide in cerebral vasospasm , 2003, Acta Neurochirurgica.

[35]  M. Schroll,et al.  Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. , 1995, Stroke.

[36]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[37]  V. Hachinski,et al.  Cardiac sequelae of acute stroke. , 1982, Stroke.

[38]  Sang Hyun Park,et al.  Plasma B-type Natriuretic Peptide Level in Patients with Acute Cerebral Infarction according to Infarction Subtype and Infarction Volume , 2012, International journal of medical sciences.

[39]  L. Almenar,et al.  Péptido cerebral natriurético. Valor diagnóstico en la insuficiencia cardíaca , 2002 .

[40]  D. Nagaraja,et al.  Preceding infection as a risk factor of stroke in the young. , 1999, The Journal of the Association of Physicians of India.

[41]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[42]  T. McDonagh,et al.  Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care , 2007, European journal of heart failure.

[43]  R. Borgohain,et al.  Chlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients , 2008, Journal of the Neurological Sciences.

[44]  Naoto Minamino,et al.  A new natriuretic peptide in porcine brain , 1988, Nature.